17-65537614-A-ATGGTGGTGG
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_004655.4(AXIN2):c.1413_1421dupCCACCACCA(p.His472_His474dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. H474H) has been classified as Likely benign.
Frequency
Consequence
NM_004655.4 disruptive_inframe_insertion
Scores
Clinical Significance
Conservation
Publications
- oligodontia-cancer predisposition syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- tooth agenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- craniosynostosisInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AXIN2 | ENST00000307078.10 | c.1413_1421dupCCACCACCA | p.His472_His474dup | disruptive_inframe_insertion | Exon 6 of 11 | 1 | NM_004655.4 | ENSP00000302625.5 | ||
| AXIN2 | ENST00000375702.5 | c.1413_1421dupCCACCACCA | p.His472_His474dup | disruptive_inframe_insertion | Exon 5 of 9 | 1 | ENSP00000364854.5 | |||
| AXIN2 | ENST00000618960.4 | c.1413_1421dupCCACCACCA | p.His472_His474dup | disruptive_inframe_insertion | Exon 6 of 10 | 5 | ENSP00000478916.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 37
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1
The c.1413_1421dupCCACCACCA variant (also known as p.H472_H474dup), located in coding exon 5 of the AXIN2 gene, results from an in-frame duplication of CCACCACCA at nucleotide positions 1413 to 1421. This results in the duplication of 3 extra residues (HHH) between codons 472 and 474. This amino acid region is not well conserved in available vertebrate species. In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at